Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-014037

CHIEF ACCOUNTING OFFICER gave up 52 shares (to pay taxes)

  • CHIEF ACCOUNTING OFFICER acquired 175 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Megna Michael R CHIEF ACCOUNTING OFFICER 2023-10-04 Option exercise +175 17,057 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2023-10-04 Shares withheld for taxes −52 $16.01 $833 17,005 D
Derivatives
Megna Michael R CHIEF ACCOUNTING OFFICER 2023-10-04 Option exercise · Restricted Share Unit −175 350 D
Loading xslF345X05/form4-10062023_081034.xml…